Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Boston Financial & Equity Corporation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 5
Rounds per year 0.11
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 4
Key employees 1

Areas of investment

  • Medical
  • Health Care
  • Biotechnology
  • Medical Device
  • Innovation Management
Summary

Boston Financial & Equity Corporation appeared to be the VC, which was created in 1968. The main department of described VC is located in the Boston. The fund was located in North America if to be more exact in United States.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2003. The top amount of exits for fund were in 2003.

Among the most popular fund investment industries, there are Innovation Management, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Angiolink Corporation. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Boston Financial & Equity Corporation, startups are often financed by Bioventures Investors. The meaningful sponsors for the fund in investment in the same round are Bioventures Investors, JHK Investments, IDP Industrial Development Partners. In the next rounds fund is usually obtained by JHK Investments, IDP Industrial Development Partners, Bioventures Investors.

The overall number of key employees were 1.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Boston Financial & Equity Corporation:
Typical Co-investors
Boston Financial & Equity Corporation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Boston Financial & Equity Corporation:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atlas Ventures Central, Central Region, Singapore
Concentric Equity Partners Chicago, Illinois, United States
Coolfire Missouri, St Louis, United States
D.BOYTER -
Freelands Ventures England, London, United Kingdom
Fuji Corporation -
Hong Kong Fahui -
Kerogen Digital Solutions -
Kettledrum Ventures -
Kimura Jitsugyo Japan, Kyoto, Kyoto Prefecture
Lysefjorden Consulting AS -
Macquarie Energy Houston, Texas, United States
Malachi -
Oyster Ventures California, San Francisco, United States
Pegavica -
Quogue Capital New York, New York, United States
Shenzhen Zowee Technology China, Guangdong, Tianjin
Startupbootcamp IoT London England, London, United Kingdom
Viessmann Allendorf-eder, Germany, Hessen
Zhuhai Yaohuihang Touzi Hehuo Qiye -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

DigitalOcean

Cloud Computing
SaaS
Software
Virtualization
Web Hosting
$83M08 Jul 2015 New York, New York, United States

Angiolink Corporation

Biotechnology
Health Care
Innovation Management
Medical
Medical Device
$13M10 Sep 2003 Taunton, Massachusetts, United States

Angiolink Corporation

Biotechnology
Health Care
Innovation Management
Medical
Medical Device
$10M17 Sep 2002 Taunton, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Boston Financial & Equity Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 21M
Rounds per year 0.11
Peak activity year 2020
Lead investments 0
Follow on index 0.17
Exits 4
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

DigitalOcean

Cloud Computing
SaaS
Software
Virtualization
Web Hosting
$83M08 Jul 2015 New York, New York, United States

Angiolink Corporation

Biotechnology
Health Care
Innovation Management
Medical
Medical Device
$13M10 Sep 2003 Taunton, Massachusetts, United States

Angiolink Corporation

Biotechnology
Health Care
Innovation Management
Medical
Medical Device
$10M17 Sep 2002 Taunton, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: